<DOC>
	<DOC>NCT01623713</DOC>
	<brief_summary>The purpose of this study is to determine whether iloperidone is effective in the treatment of Schizophrenia.</brief_summary>
	<brief_title>Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Men or women ages 1865 years old. DSMIV diagnosis of schizophrenia. PANSS≥70. Of the 7 PANSS positive symptom subscale, at least two score ≥ 4 points. Written informed consent. Pregnant or nursing (lactating) women, or women who plan on conceiving during the course of the study. Clinically significant disease of the heart,kidneys,liver,hematonosis or endocrine system.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>iloperidone</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>